# Topical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) Anesthesia

> **NCT01746940** · PHASE3 · TERMINATED · sponsor: **Lannett Company, Inc.** · enrollment: 159 (actual)

## Conditions studied

- Diagnostic
- Procedures and Surgeries on or Through Accessible Mucous Membranes
- of the Nasal Cavities

## Interventions

- **DRUG:** Cocaine HCl 4% Topical Solution
- **DRUG:** Cocaine HCl 10% Topical Solution
- **DRUG:** Placebo Topical Solution

## Key facts

- **NCT ID:** NCT01746940
- **Lead sponsor:** Lannett Company, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 159 (ACTUAL)
- **Why stopped:** Trial operational issues.
- **Last updated:** 2017-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01746940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01746940, "Topical Application of Cocaine HCl 4% and 10% on Safety and Efficacy in Local (Topical) Anesthesia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01746940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*